Neos Therapeutics Inc (NEOS):企業の財務・戦略的SWOT分析

◆英語タイトル:Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH187693FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Neos Therapeutics Inc (NEOS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Neos Therapeutics Inc (Neos Therapeutics) develops, manufactures, and commercializes medicines for the treatment of attention deficit hyperactivity disorder (ADHD) based on its proprietary extended-release (XR) drug delivery technology platform. The company’s portfolio includes branded and generic pharmaceuticals indicated for the treatment of ADHD in patients of six years age and older; and a generic pharmaceutical for the treatment of cough and upper respiratory symptoms of cold. It is investigating its pipeline candidate, NT0502 for the treatment of ADHD. The company’s products are orally disintegrating tablets (ODT) or liquid suspension dosage forms. Neos Therapeutics is headquartered in Grand Prairie, Texas, the US.

Neos Therapeutics Inc Key Recent Developments

Nov 09,2020: Neos Therapeutics reports third quarter 2020 financial results
Aug 10,2020: Neos Therapeutics reports second quarter 2020 financial results
May 11,2020: Neos Therapeutics reports first quarter 2020 financial results
Apr 18,2020: Neos Therapeutics receives loan under Paycheck Protection Program
Mar 30,2020: Neos Therapeutics statement: COVID-19 update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Neos Therapeutics Inc – Key Facts
Neos Therapeutics Inc – Key Employees
Neos Therapeutics Inc – Key Employee Biographies
Neos Therapeutics Inc – Major Products and Services
Neos Therapeutics Inc – History
Neos Therapeutics Inc – Company Statement
Neos Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Neos Therapeutics Inc – Business Description
Product Category: Adzenys ER
Overview
Performance
Product Category: Adzenys XR-ODT
Overview
Performance
Product Category: Cotempla XR-ODT
Overview
Performance
Product Category: Generic Tussionex
Overview
Performance
R&D Overview
Neos Therapeutics Inc – Corporate Strategy
Neos Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Neos Therapeutics Inc – Strengths
Neos Therapeutics Inc – Weaknesses
Neos Therapeutics Inc – Opportunities
Neos Therapeutics Inc – Threats
Neos Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Neos Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 09, 2020: Neos Therapeutics reports third quarter 2020 financial results
Aug 10, 2020: Neos Therapeutics reports second quarter 2020 financial results
May 11, 2020: Neos Therapeutics reports first quarter 2020 financial results
Apr 18, 2020: Neos Therapeutics receives loan under Paycheck Protection Program
Mar 30, 2020: Neos Therapeutics statement: COVID-19 update
Mar 13, 2020: Neos Therapeutics reports fourth quarter and year-end 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Neos Therapeutics Inc, Key Facts
Neos Therapeutics Inc, Key Employees
Neos Therapeutics Inc, Key Employee Biographies
Neos Therapeutics Inc, Major Products and Services
Neos Therapeutics Inc, History
Neos Therapeutics Inc, Subsidiaries
Neos Therapeutics Inc, Key Competitors
Neos Therapeutics Inc, Ratios based on current share price
Neos Therapeutics Inc, Annual Ratios
Neos Therapeutics Inc, Annual Ratios (Cont...1)
Neos Therapeutics Inc, Interim Ratios
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Neos Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Neos Therapeutics Inc (NEOS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Photo-Me International plc (PHTM):企業の財務・戦略的SWOT分析
    Summary Photo-Me International Plc (Photo-Me) is a consumer goods provider that offers photographic products. The company offers optical and instant service equipment. It operates a range of vending equipment such as self-service launderettes, digital printing kiosks, children rides and amusement ma …
  • Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transport …
  • Beazer Homes USA Inc:企業の戦略・SWOT・財務情報
    Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Baron Oil Plc (BOIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • Mitsui & Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Telecom Corporation Limited:企業の戦略・SWOT・財務情報
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Trade Me Group Limited:企業の戦略・SWOT・財務情報
    Trade Me Group Limited - Strategy, SWOT and Corporate Finance Report Summary Trade Me Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • TiGenix NV (TIG):医療機器:M&Aディール及び事業提携情報
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Royal Dutch Shell Plc (RDSA)-石油・ガス分野:企業M&A・提携分析
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Enerjisa Enerji AS:電力:M&Aディール及び事業提携情報
    Summary Enerjisa Enerji AS (Enerjisa Enerji) is a power generation company. The company operates in the business of distribution, and sale of electricity. It provides electricity wholesale and retail services, marketing, products and services development, energy management, and energy consultancy se …
  • Southern Company Gas:企業の戦略的SWOT分析
    Southern Company Gas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Owens-Illinois, Inc.:企業の戦略・SWOT・財務分析
    Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Its products are based on 3D antigens designed …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Extendicare Inc.:企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆